Ovagen
Also known as: Glu-Asp-Leu, EDL
Popular For
Liver support, GI health, detoxification
Key Facts: Ovagen
- Category
- Bioregulators
- FDA Status
- Not FDA Approved
- Clinical Status
- Preclinical research, approved in Russia as supplement
- Administration
- Oral capsules or sublingual
- Typical Dose
- 10-20 mg daily
- Frequency
- Once or twice daily
- Evidence Level
- Preclinical
- Duration
- 10-30 day cycles
Mechanism of Action
Ovagen interacts with intracellular regulatory systems, modulating chromatin structure and transcription-factor accessibility. In hepatic and GI systems, it influences markers of cellular proliferation, extracellular matrix organization, and mucosal signaling pathways. Supports protein synthesis and antioxidant defense mechanisms.
Research Summary
Research focuses on hepatoprotective and GI mucosal support properties. Studies show modulation of gene expression patterns in liver tissue models. Part of the Khavinson peptide bioregulator family with tissue-specific regulatory effects.
Dosing Information
Note: Animal study doses may not translate directly to humans.
Typical Dosingⓘ
Community experience
10-20 mg daily
10-20 mg daily
Once or twice daily
Khavinson bioregulator for liver/GI. Part of the peptide bioregulator system.
Research Dosingⓘ
Scientific studies
Doses from bioregulator supplement protocols
Doses from Studies
10-20 mg daily
Duration
10-30 day cycles
Administration
Oral capsules or sublingual
Timing & Administration
Best Time to Take
Morning on empty stomach
Once or twice daily
Food Recommendation
Take on empty stomach
Why This Timing?
Peptide bioregulators typically taken fasted for optimal absorption
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Generally well-tolerated
- ●Limited safety data outside Russia
- ●Not FDA approved
References
Related Peptides
Peptides commonly compared with Ovagen or used in similar applications.
Livagen
PreclinicalA tetrapeptide bioregulator (Lys-Glu-Asp-Ala) developed by Khavinson that modulates chromatin structure and gene expression. Research shows it can decondense heterochromatin and activate ribosomal genes, potentially restoring more youthful gene expression patterns in aging cells.
BioregulatorsCortagen
PreclinicalA tetrapeptide bioregulator (Ala-Glu-Asp-Pro) derived from cerebral cortex extracts. Studied for neuroprotection, neural differentiation, and cognitive support. Regulates neurotrophic signaling and synaptic stability.
BioregulatorsVesugen
PreclinicalA tripeptide bioregulator (Lys-Glu-Asp) targeting vascular tissue. Promotes restoration of blood vessel tissues and normalization of vascular function. Stimulates endothelial cell proliferation markers.
BioregulatorsChonluten
PreclinicalA tripeptide bioregulator targeting respiratory and lung tissue. Supports healthy lung function and stomach lining. Regulates inflammatory and proliferative processes in respiratory epithelium.
BioregulatorsCrystagen
PreclinicalA tripeptide bioregulator supporting immune system function. Demonstrates age-associated immunoprotective properties in spleen tissue. Part of the Khavinson synthesized peptide series.
BioregulatorsProstamax
PreclinicalA peptide bioregulator targeting prostate tissue. One of five highly efficient synthesized peptides developed by Khavinson with demonstrated effects on gene expression and tissue-specific regulation.
BioregulatorsLooking for a trusted vendor?
Pro members get access to verified vendors with quality standards & exclusive discount codes.
Want updates on Ovagen research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.